Public research preview

Gilbert Cisneros, Representative disclosure: BridgeBio Pharma, Inc. - Common Stock (BBIO)

Disclosed a buy transaction in BridgeBio Pharma, Inc. - Common Stock (BBIO). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
63/100
Data Confidence
93%
high

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
12 Sept 2025, 00.00
Parser confidence
94%
Instrument mapping
95%
Filing delay
35 days

Timeline

Transaction date

8 Aug 2025

Public disclosure

12 Sept 2025

Now

Tracked today

Filing delay: 35 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

Most of the move happened before this disclosure became public: the stock peaked +16.6% above the transaction-date close and has since retraced -5.7% from that peak. Buying now is a pullback entry on the disclosed position, not a fresh breakout.

Stock path

BBIO from pre-transaction context through latest close.

Bought

8 Aug 2025 ยท 46,58 USD

46,663,279,9USDDate8 Aug12 Sept8 JunBoughtDisclosureLatest
Observed transaction close
46,58
Observed disclosure close
51,21
Observed latest close
67,37
Pre-disclosure move
+9.9%
Post-disclosure move
+31.6%
Market-adjusted move
+31.6%
Pre-disclosure peak run-up
+16.6%
Retrace from peak
-5.7%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 12 Sept 2025, 00.00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerBBIO
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20031022.pdf
personNameGilbert Cisneros
amountRange$1,001 - $15,000
companyNameBridgeBio Pharma, Inc. - Common Stock (BBIO)
publishedAt2025-09-12T00:00:00.000Z
rawDocumentIdraw-us-house-20031022-9
disclosureDate2025-09-12
transactionDate2025-08-08
transactionTypeP